Citation Impact
Citing Papers
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Epidemiology and causes of preterm birth
2008 Standout
ERβ: Identification and characterization of a novel human estrogen receptor
1996 Standout
Implantation and the Survival of Early Pregnancy
2001
Kidney stones: pathophysiology and medical management
2006 Standout
Estrogen Receptors: How Do They Signal and What Are Their Targets
2007 Standout
Oxyl radicals, redox-sensitive signalling cascades and antioxidants
2007 Standout
A blueprint for the prevention of preterm birth: vaginal progesterone in women with a short cervix
2013
Mechanisms of progesterone action in inhibiting prematurity
2006
Antioxidant: a new role for RU-486 and related compounds.
1994
Endometriosis
2009 Standout
Cushing's syndrome
2015 Standout
Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on cell growth and the secretion of the estrogen-induced 34-, 52- and 160-kDa proteins in human breast cancer cells
1990
Changes in Parameters of Bone and Mineral Metabolism during Therapy for Hyperthyroidism
2000
Guillain-Barré syndrome
2016 Standout
Cloning, in vitro expression, and tissue distribution of a human prostaglandin transporter cDNA(hPGT).
1996
Vitamin D Deficiency
2007 Standout
Interventions for emergency contraception
2012
Molecular Cloning of the Gene for the Human Prostaglandin Transporter hPGT: Gene Organization, Promoter Activity, and Chromosomal Localization
1998
Clinical Pharmacokinetics in Organ Transplant Patients
1989
Selective Progesterone Receptor Modulators (SPRMs)
2002
Enzyme Replacement Therapy in Fabry Disease
2001 Standout
Hyperthyroidism, Thyroid Hormone Therapy, and Bone
1994
Fabry disease: Guidelines for the evaluation and management of multi-organ system involvement
2006
Follow-up of five patients with FHHNC due to mutations in the Paracellin-1 gene
2002
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
New medical treatments for endometriosis
2004
Protecting adolescents from harm. Findings from the National Longitudinal Study on Adolescent Health
1997 Standout
Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data
2011
Mifepristone (RU486) alone or in combination with a prostaglandin analogue for termination of early pregnancy: a review
1991
Mifepristone (RU486): A review
1997
Holt-Oram syndrome is caused by mutations in TBX5, a member of the Brachyury (T) gene family
1997 Standout
Renal lipid metabolism and lipotoxicity
2010
Estrogen-progestins and progestins for the management of endometriosis
2016
Stress and the brain: from adaptation to disease
2005 Standout
How were new medicines discovered?
2011 Standout
Synthetic approaches to the 2009 new drugs
2010
Subclinical Thyroid Disease
2004 Standout
Endometriosis
2010 Standout
Eicosanoids and the gastrointestinal tract
1995
The efficacy of intrauterine devices for emergency contraception: a systematic review of 35 years of experience
2012
Comparison of Two Diets for the Prevention of Recurrent Stones in Idiopathic Hypercalciuria
2002 Standout
Endometriosis
2004 Standout
Inflammatory bowel disease: Etiology and pathogenesis
1998 Standout
Demographic and geographic variability of kidney stones in the United States
1994
Obstructive sleep apnoea and its cardiovascular consequences
2008 Standout
Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E–deficient mice
2000 Standout
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Infection in Organ-Transplant Recipients
1998 Standout
Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2
1995 Standout
Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting
2015 Standout
LYSOSOMAL STORAGE DISEASES
1991
Genetic Hypercalciuria
2005
Mechanisms of implantation: strategies for successful pregnancy
2012 Standout
An open label trial of C-1073 (mifepristone) for psychotic major depression*
2002
Relative in Vitro Efficacy of the Phosphate Binders Lanthanum Carbonate and Sevelamer Hydrochloride
2007 StandoutNobel
Induction of Abortion with Mifepristone (RU 486) and Oral or Vaginal Misoprostol
1995
Magnesium in Man: Implications for Health and Disease
2014 Standout
Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications
2019 Standout
Developmental effects of endocrine-disrupting chemicals in wildlife and humans.
1993 Standout
Endocrine and Paracrine Regulation of Birth at Term and Preterm*
2000 Standout
Identification and Characterization of a Prostaglandin Transporter
1995 Science
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
Abortion surveillance--United States, 1992.
1996
Lectins: Carbohydrate-Specific Proteins That Mediate Cellular Recognition
1998 Standout
Prospective Study of Heart Rate Variability and Mortality in Chronic Heart Failure
1998 Standout
Guidelines for the Primary Prevention of Stroke
2014 Standout
MOLECULAR MECHANISMS OF PROSTAGLANDIN TRANSPORT
1998
Physiological and Molecular Basis of Thyroid Hormone Action
2001 Standout
Cloning of mouse prostaglandin transporter PGT cDNA: species-specific substrate affinities
1999
Mechanisms of Estrogen Action
2001 Standout
Effects of Thyroid Hormones on Bone and Mineral Metabolism
1990
Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology
2001 StandoutScience
In vivo effects of the antiglucocorticoid RU 486 on glucocorticoid and cytokine responses to Escherichia coli endotoxin
1992
The Steroid Hormone Antagonist RU486: Mechanism at the Cellular Level and Clinical Applications
1991
How Do Glucocorticoids Influence Stress Responses? Integrating Permissive, Suppressive, Stimulatory, and Preparative Actions*
2000 Standout
Evidence for Disordered Control of 1,25-Dihydroxyvitamin D Production in Absorptive Hypercalciuria
1984
Contragestion and Other Clinical Applications of RU 486, an Antiprogesterone at the Receptor
1989 Science
Possible use of glucocorticoid receptor antagonists in the treatment of major depression: preliminary results using RU 486.
1993
Endometriosis
2020 Standout
Estrogen Receptor β Activates the Human Retinoic Acid Receptorα -1 Promoter in Response to Tamoxifen and Other Estrogen Receptor Antagonists, but Not in Response to Estrogen
1999
Brain Corticosteroid Receptor Balance in Health and Disease*
1998 Standout
Role of infection in Guillain-Barr� syndrome: Laboratory confirmation of herpesviruses in 41 cases
1981
Preterm labor: One syndrome, many causes
2014 StandoutScience
Major Facilitator Superfamily
1998 Standout
Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens.
1995
Natural Products as Sources of New Drugs from 1981 to 2014
2016 Standout
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Prevalence of Fabry Disease in Female Patients With Late-Onset Hypertrophic Cardiomyopathy
2004
Bone metabolism and disease in chronic kidney disease
2003
Spectral Analysis of Blood Pressure and Heart Rate Variability in Evaluating Cardiovascular Regulation
1995
Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities.
1995 Standout
Interventions for emergency contraception
2017
Recommendations for Blood Pressure Measurement in Humans and Experimental Animals
2005 Standout
Works of André Ulmann being referenced
Effect of body weight and BMI on the efficacy of levonorgestrel emergency contraception
2014
Termination of early pregnancy by a single dose of mifepristone (RU 486), a progesterone antagonist
1988
Transplacental passage of a progesterone antagonist in monkeys
1988
Tolerance of perinidatory primate embryos to RU 486 exposure and
1990
Noncompetitive antiestrogenic effect of RU 486 in blocking the estrogen-stimulated luteinizing hormone surge and the proliferative action of estradiol on endometrium in castrate monkeys
1989
Treatment of endometriosis with the antiprogesterone mifepristone (RU486)
1996
Early Termination of Pregnancy with Mifepristone (RU 486) and the Orally Active Prostaglandin Misoprostol
1993
Can we identify women at risk of pregnancy despite using emergency contraception? Data from randomized trials of ulipristal acetate and levonorgestrel
2011
Progesterone antagonist (RU 486) for cervical dilation, labor induction, and delivery in monkeys: Effectiveness in combination with oxytocin
1989
Contraceptive potential of RU 486 by ovulation inhibition: III. Preliminary observations on once weekly oral administration
1989
Voluntary Interruption of Pregnancy with Mifepristone (RU 486) and a Prostaglandin Analogue
1990
Comparative effects of 17β-estradiol, progestin R5020, tamoxifen and RU38486 on lactate dehydrogenase activity in MCF-7 human breast cancer cells
1989
Medical termination of early pregnancy with mifepristone (RU 486) followed by a prostaglandin analogue: Study in 16, 369 women
1992
Mifepristone (RU486) and therapeutic late pregnancy termination: a double-blind study of two different doses
1988
Effects of the converting enzyme inhibitor trandolapril on short-term variability of blood pressure in essential hypertension
1991
Contraceptive potential of ru 486 by ovulation inhibition: II. suppression of pituitary gonadotropin secretion
1989
Contraceptive potential of RU 486 by ovulation inhibition: I. Pituitary versus ovarian action with blockade of estrogen induced endometrial proliferation
1989
Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis
2010
Pregnancy interruption with RU 486 in combination with dl-15-methyl-prostaglandin-F2α-methyl ester: The Chinese experience
1988
Can We Identify Women at Risk of Pregnancy Despite Using Emergency Contraception? Data From Randomized Trials of Ulipristal Acetate and Levonorgestrel
2013
Contragestion with late luteal administration of RU 486 (Mifepristone)
1988
Termination of Early Pregnancy by the Progesterone Antagonist RU 486 (Mifepristone)
1986
Elevated metabolic clearance rate of 1α,25-dihydroxyvitamin D3 in hyperthyroidism
1985
Effect of plasma levels of parathyroid hormone on NADPH pathways in kidney and liver
1985
Chronic Hypophosphatemia in Kidney Transplanted Children and Young Adults
1980
Endocrine responses to long-term administration of the antiprogesterone RU486 in patients with pelvic endometriosis
1991
Early renal changes in hemizygous and heterozygous patients with Fabry's disease
1978
Effects of Weight and Glucose Ingestion on Urinary Calcium and Phosphate Excretion: Implications for Calcium Urolithiasis
1982
Measles virus and Guillain-Barré syndrome during long-term hemodialysis
1976
Uses of RU 486 for contragestion: An update
1987
Renal Magnesium and Phosphate Wastage in a Patient with Hypercalciuria and Nephrocalcinosis: Effect of Oral Phosphorus and Magnesium Supplements
1985